Drawing for KETOD

USPTO serial 79412617

KETOD

Reviewed by CopyMark Law Group

Reg. 8072759Status 700Registered
Filing date
Status date
Registration date
Dec 23, 2025
Examiner
LATTUCA, FRANK J
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with KETOD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kumiko Ide

Kumiko Ide Wenderoth, Lind & Ponack, L.L.P.1025 Connecticut Avenue NW, Suite 500Washington, DC 20036United States

Goods and services

ClassDescriptionStatusFirst use
001Lactic acid bacteria powder for producing food, dietary supplements for humans or beverages; other microorganism, namely, bacteria and bacteria powder for producing food, dietary supplements for humans or beverages; polysaccharides for producing food, dietary supplements for humans or beverages; chemical products for the fresh-keeping and preserving of food; glue and adhesives for industrial purposes; plant growth regulating preparations; fertilizers; ceramic glazings in the nature of a dry chemical preparation for use in the manufacture of ceramics; priming glazers putty; higher fatty acids for industrial purposes; alkaline metals; alkaline-earth metals; non-metallic industrial minerals, namely, silica, feldspar, limestone, gypsum, talc; chemical compositions for developing and printing photographs; reagent paper not for medical purposes; artificial sweeteners for industrial purposes; flour and starch for industrial purposes; unprocessed plastics; groundwood pulp and chemical pulps for manufacturing purposes; proteins for the food industry.ACTIVE—
005Pharmaceutical preparations other than for agricultural purposes for the treatment and prevention of metabolic and endocrine diseases, namely, diabetes, diabetic complication, hyperlipidemia, hyperuricemia, gout, lifestyle related disease, nutritional disorders, impaired glucose tolerance, metabolic syndrome, obesity and lipid disorder, cardiovascular, urological and reproductive diseases, namely, hypertension, hyperglycemia, ischemic heart disease, hyperinsulinemia, arteriosclerosis, myocardial infarction, angina pectoris, aneurysm, chronic kidney disease, renal calculi, kidney disease, pyelonephritis, nephritis, urethritis, cystitis, hypercholesterolemia and high triglyceridemia, respiratory diseases, namely, bronchitis, pulmonary emphysema and lung inflammation, digestive and oral diseases, namely, abnormality of the intestinal flora, abdominal distension, peptic ulcer, intestinal disease, inflammatory disorder, irritable bowel syndrome, gastric ulcer, inflammatory bowel disease, Crohn's disease, diverticulitis, liver cirrhosis, fatty liver, diarrhea, constipation, loose stool disease, hepatic inflammation, non-alcoholic steatohepatitis, viral hepatitis, alcoholic hepatitis, dental disease, periodontal diseases, stomatitis, xerostomia and cyst, immune, inflammatory and allergic diseases, namely, immune related diseases and abnormalities, type I, II, III, IV and V allergy, pollinosis, atopic dermatitis, psoriasis, autoimmune disease and connective tissue disease, bone and articular diseases, namely, rheumatism, osteoporosis and articular inflammation, pathogenic microbial and malignant neoplastic diseases, namely, infection, cancer and malignant tumor, mental and nervous system diseases, namely, mental disorder, dementia, Alzheimer's disease, bipolar disorder, depression, anorexia, insomnia, cerebral apoplexy, cerebral infarction, autism, neuroinflammation, overwork related disease and nerve inflammation related diseases and cancers resulting from chronic inflammation, and sensory system and skin diseases, namely, ophthalmic disease, ocular inflammation, otorhinolaryngology disease and skin inflammation; pharmaceutical preparations in the nature of medicines for dental purposes; reagent paper for medical purposes; fumigants only for agricultural purposes; fungicides only for agricultural purposes; rodenticides only for agricultural purposes; insecticides only for agricultural purposes; herbicides being weedkillers; insect-repellents only for agricultural purposes; antiseptics only for agricultural purposes; oiled paper for medical purposes; adhesive tapes for medical purposes; drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; liquid bandages for skin wounds; breast-nursing pads; cotton swabs for medical use; dental composite materials; diapers; diaper covers; fly catching paper; mothproofing paper; lacteal flour for babies; dietary supplements for human beings; dietetic beverages adapted for medical purposes; dietetic foods adapted for medical purposes; beverages for babies namely, infant formula; food for babies; dietary supplements for animals; semen for artificial insemination.ACTIVE—
029Edible oils and fats; milk products excluding ice cream, ice milk and frozen yogurt; fresh, chilled, and frozen meat for human consumption; eggs; fresh, chilled and frozen edible aquatic animals for human consumption; frozen vegetables; frozen fruits; processed meat products, namely, dried meat and chicken, meat, or fish croquettes, sausages, ham and bacon; processed seafood products other than blocks of boiled, smoked and then dried bonitos, dried pieces of agar jelly, flakes of dried fish meat, fishmeal for human consumption, edible shavings of dried kelp, sheets of dried laver, dried brown alga, dried edible seaweed and toasted sheets of laver; blocks of boiled, smoked and then dried bonitos namely, katsuo-bushi; dried pieces of agar jelly namely, kanten; flakes of dried fish meat namely, kezuri-bushi; fish meal for human consumption; edible shavings of dried kelp namely, tororo-kombu; sheets of dried laver namely, hoshi-nori; dried brown alga namely, hoshi-hijiki; dried edible seaweed namely, hoshi-wakame; toasted sheets of laver namely, yaki-nori; processed vegetables and fruits; fried tofu pieces namely, abura-age; freeze-dried tofu pieces namely, kohri-dofu; jelly made from devils' tongue root namely, konnyaku; soya milk; tofu; fermented soybeans namely, natto; processed eggs; pre-cooked curry stew, stew and soup mixes; dried flakes of laver for sprinkling on rice in hot water namely, ochazuke-nori; furi-kake namely, dried flakes of fish, meat, vegetables or seaweed; side-dish made of fermented soybean namely, name-mono; preserved pulses namely, azuki, green beans.ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 23, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 2, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jul 2, 2026FIMPFINAL DISPOSITION PROCESSED—
Jun 4, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
May 18, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
May 18, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 23, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 23, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 23, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 4, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 4, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 29, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 7, 2025PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Oct 6, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 2, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 2, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 2, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 19, 2025RFNTREFUSAL PROCESSED BY IB—
Apr 3, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 3, 2025RFRRREFUSAL PROCESSED BY MPU—
Mar 2, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 1, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 27, 2025DOCKASSIGNED TO EXAMINER—
Dec 26, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 26, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 19, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance